RADIOCHEMISTRY

***Teaser Text***

Development of radiochemical labelling process

We take your lead compound from paper to reality and develop a robust and GMP compliant automated synthesis process. Our core competence is finding the optimal radiochemical labelling conditions of your lead compound with a variety of radionuclides (F-18, Ga-68, Lu-177, I-123, …), followed by its purification and formulation to a Drug Product. Development includes stability and formulation studies to provide a safe and stable solution for the patient.

With six hot cells dedicated for development and the largest variety of radiopharmaceutical synthesizers in the world ABX is your preferred partner when it comes to radiopharmaceuticals. Quality starts for us already in development. Our developmental facility is equipped with state-of-the-art Quality Control equipment to ensure development of robust Quality Control methods.